ArticleOncotarget2017

T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.

Wen Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.